Products

Synfini is an AI-driven drug discovery platform that integrates artificial intelligence, chemistry automation, and cloud-native workflows to accelerate the development of small molecule therapeutics. By uniting physical and virtual chemistry through expert-curated AI and discovery-focused robotic automation, Synfini dramatically reduces the time and cost associated with translating targets, hits, and virtual drug concepts into validated candidates. This innovative approach enables partners to cr

BioLM is an AI-driven platform specializing in enzyme and therapeutics design, discovery, and optimization. It offers custom AI workflows, in-silico variant analysis, and seamless integration of AI into wet-lab projects, catering to the biotech and life science industries. Founded in 2022 and based in Shingle Springs, California, BioLM provides scalable solutions for protein and DNA modeling, including secure tokenization, regression, classification, de novo generation, and folding. Users can ac

We offer a full range of consulting, development and commercialisation services from a global network of offices in 37 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas

Antiverse is a biotechnology company specializing in computational antibody drug discovery. By integrating machine learning with in-house laboratory expertise, Antiverse aims to expedite the development of therapeutic antibodies, particularly targeting challenging proteins like G-protein-coupled receptors (GPCRs) and ion channels. Their platform is designed to predict antibody-antigen interactions, facilitating the rapid identification of potential drug candidates.

DeepCure is a biotechnology company specializing in the development of small molecule therapeutics for immune diseases. Their pipeline includes oral treatments targeting conditions such as rheumatoid arthritis, Still's disease, hidradenitis suppurativa, asthma, and atopic dermatitis. By focusing on innovative drug discovery, DeepCure aims to provide effective solutions for patients suffering from these autoimmune and inflammatory disorders.

Nieuw Amsterdam Advisors is an international life sciences consultant practice focused on discovering an elite group of best in class therapeutic, diagnostic and med tech firms that are truly game changing.Our global team is passionate about being on the forefront of providing the expert multilevel support needed to bring this next generation of breakthrough discovery class to the world stage and be a positive force in world health.

Emosapien is an AI co-therapist for mental health professionals, designed to support clinicians during and after sessions with real-time therapeutic guidance, progress notes, and client engagement (so care continues between appointments). Emosapien brings key workflows into one place, including intake, live-session support, and AI-assisted progress notes, while keeping security front and center with HIPAA-ready protection and clinical-grade safeguards.

Talus Bio is a biotechnology company specializing in the discovery and development of therapeutics targeting previously undruggable transcription factors—proteins that regulate gene expression and are implicated in various diseases, including cancer, diabetes, and neurological conditions. Founded in 2020 and based in Seattle, Talus Bio integrates advanced proteomics, synthetic chemistry, artificial intelligence, and computational biology to engineer and analyze drugs, proteins, and genomics at a

Leash Biosciences is a biotechnology company dedicated to revolutionizing drug discovery by integrating machine learning with extensive biochemical data. By screening millions of compounds against thousands of proteins, Leash generates billions of data points, creating a rich dataset ideal for training advanced machine learning models. This approach aims to bridge the existing data gap in medicinal chemistry, facilitating the rapid design of novel small molecule therapeutics.

Anthill is a specialist digital agency and a strategic partner for life science companies – providing customer-relevant content that brings e-detailing, closed loop marketing, and multichannel communications alive. We are working globally with leading life science companies including: Amgen, Bayer, Biogen, Grünenthal, Mölnlycke, Pfizer, and Roche. In pharma, we have experience in more than 30 therapeutic areas and work at all stages of a product's lifecycle.

LabGenius is a pioneering biopharmaceutical company that leverages machine learning and automation to revolutionize the discovery and optimization of complex protein therapeutics. Their proprietary platform, EVA™, integrates advanced technologies from machine learning, synthetic biology, and robotics to design, build, and test novel antibody-based treatments efficiently. This approach enables the rapid evaluation of vast numbers of multispecific antibodies, leading to the identification of high-

Sorcero is the leading life sciences language intelligence platform. Its advanced analytics enable 40% of the top 10 global life sciences organizations to gain clarity and complete visibility on the efficacy and impact of their scientific engagement on patient outcomes. Medical and regulatory affairs teams rely on Sorcero to 10x their productivity, generate evidence, manage insights, and transform their medical strategy with real-time advanced analytics across the therapeutic landscape.

Profluent Bio's platform leverages advanced artificial intelligence to design and generate novel proteins, transcending traditional methods of random discovery. By integrating frontier foundation models with an in-house wet laboratory, Profluent enables the creation of proteins tailored for specific applications, ranging from therapeutics to industrial enzymes. This AI-driven approach allows for the design of proteins inspired by natural scaffolds or entirely reimagined structures, offering solu

The Hailo-8L Entry-Level AI Accelerator is a compact and efficient processor designed to bring advanced artificial intelligence capabilities to entry-level edge devices. With a performance of up to 13 tera-operations per second (TOPS), it enables real-time AI processing in applications that require limited AI capacity or lower performance. Its superior area and power efficiency make it an ideal solution for integrating AI functionalities into cost-sensitive and space-constrained devices.

Noetik is an AI-native biotechnology company dedicated to revolutionizing cancer treatment through the discovery and development of precision immunotherapies. By integrating advanced machine learning techniques with extensive human multimodal data—including genomics, transcriptomics, and proteomics—Noetik aims to construct foundational models of cell and tissue biology. This innovative approach enables a deeper understanding of tumor-immune interactions, facilitating the identification of novel

Ganymede is a cutting-edge, AI-native assay analysis tool designed to revolutionize scientific workflows in the life sciences industry. It connects directly to instruments and integrates with Electronic Laboratory Notebooks (ELNs) and Laboratory Information Management Systems (LIMS), automating data analysis and reducing manual labor. Modular Analysis offers customizable apps for various workflows, starting with bioprocess analysis, and supports applications in small molecules, biologics, cell &

CytoReason is a pioneering technology company specializing in the development of computational disease models that simulate human diseases at the cellular and tissue levels. By integrating vast datasets, including omics data and cell-focused natural language processing, CytoReason's platform provides a comprehensive understanding of disease mechanisms, patient variability, and treatment effects. This innovative approach enables pharmaceutical and biotech companies to identify new therapeutic tar

AMPLY Discovery is revolutionizing drug discovery by integrating artificial intelligence with natural evolutionary processes to identify novel medicines. By digitizing biological data through next-generation sequencing, AMPLY's platform analyzes vast datasets to uncover potential therapeutic compounds. These digital discoveries are then bio-printed into tangible molecules for real-world testing, ensuring practical applicability. This innovative approach has been validated in leading hospital lab

BioAI Health is a biotechnology company specializing in the development of advanced machine learning technologies to map the causal biology of diseases, create digital biomarkers, and identify novel drug targets. Their mission is to revolutionize precision medicine by accelerating clinical research and development through AI-powered solutions. Key Features and Functionality: - PredictX Platform: A cutting-edge multimodal AI platform capable of ingesting diverse data types, including digital pa

Intrepid Labs is a biotechnology research company founded in 2023, dedicated to accelerating the development of next-generation therapeutics by integrating active machine learning, advanced robotics, and deep pharmaceutical expertise. Their proprietary platform, VALIANT, is a modular, autonomous laboratory that leverages data-driven experiment planning to optimize drug formulations. By combining artificial intelligence and robotics, Intrepid Labs aims to transform active pharmaceutical ingredien